In the present work, the presence of BCR-ABL1-expressing LSCs was investigated in CD34+ cells isolated from the bone marrow of 21 CML patients in sustained deep molecular response induced with a first-line Imatinib or Dasatinib. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.